Answer
Small decreases in bone mineral density have been observed in clinical studies of HIV-negative people taking emtricitabine/tenofovir disoproxil for PrEP.
Sources for this answer
- Emtricitabine/Tenofovir disoproxil Dr. Reddy's 200 mg/245 mg Film-Coated TabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 11Document updated
Sources checked